SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005892
Filing Date
2020-05-08
Accepted
2020-05-08 09:06:13
Documents
87
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20200331x10q.htm 10-Q 1519693
2 EX-10.1 mrsn-20200331ex101321160.htm EX-10.1 68522
3 EX-10.2 mrsn-20200331ex102c455ed.htm EX-10.2 57080
4 EX-10.3 mrsn-20200331ex1032c0f0b.htm EX-10.3 48579
5 EX-31.1 mrsn-20200331ex3119fbe27.htm EX-31.1 11931
6 EX-31.2 mrsn-20200331ex312ff7ed4.htm EX-31.2 13649
7 EX-32.1 mrsn-20200331ex32181f310.htm EX-32.1 16051
8 GRAPHIC mrsn20200331ex102c455ed001.jpg GRAPHIC 4510
9 GRAPHIC mrsn20200331ex1032c0f0b001.jpg GRAPHIC 6924
  Complete submission text file 0001558370-20-005892.txt   6907020

Data Files

Seq Description Document Type Size
10 EX-101.INS mrsn-20200331.xml EX-101.INS 1462443
11 EX-101.SCH mrsn-20200331.xsd EX-101.SCH 52866
12 EX-101.CAL mrsn-20200331_cal.xml EX-101.CAL 57388
13 EX-101.DEF mrsn-20200331_def.xml EX-101.DEF 190515
14 EX-101.LAB mrsn-20200331_lab.xml EX-101.LAB 461414
15 EX-101.PRE mrsn-20200331_pre.xml EX-101.PRE 378647
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 20858941
SIC: 2834 Pharmaceutical Preparations